PTC Therapeutics, Inc. announced that on May 11, 2020 it approved non-statutory stock options to purchase an aggregate of 50,025 shares of its common stock and 4,470 restricted stock units, each representing the right to receive one share of its common stock upon vesting, to seven new employees.
May 15, 2020
· 2 min read